Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial

BACKGROUND: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and effective for sudden cardiac death prevention. However, patients in previous S-ICD studies had fewer comorbidities, had less left ventricular dysfunction, and received more inappropriate shocks (IAS) than in ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Michael R., Lambiase, Pier D., El-Chami, Mikhael F., Knops, Reinoud E., Aasbo, Johan D., Bongiorni, Maria Grazia, Russo, Andrea M., Deharo, Jean-Claude, Burke, Martin C., Dinerman, Jay, Barr, Craig S., Shaik, Naushad, Carter, Nathan, Stoltz, Thomas, Stein, Kenneth M., Brisben, Amy J., Boersma, Lucas V.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752215/
https://www.ncbi.nlm.nih.gov/pubmed/33073614
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.048728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752215/
https://www.ncbi.nlm.nih.gov/pubmed/33073614
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.048728

Ejemplares similares